Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
24.80B | 23.85B | 39.40B | 32.80B | 20.38B |
Gross Profit | ||||
8.67B | 8.79B | 5.96B | 5.38B | 3.40B |
EBIT | ||||
0.00 | 2.63B | 3.80B | 2.96B | 1.06B |
EBITDA | ||||
2.50B | 2.76B | 4.60B | 3.70B | 1.81B |
Net Income Common Stockholders | ||||
1.18B | 1.43B | 2.64B | 2.03B | 788.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
1.15B | 2.07B | 3.78B | 2.31B | 1.70B |
Total Assets | ||||
11.72B | 10.97B | 14.75B | 14.65B | 9.85B |
Total Debt | ||||
2.35B | 1.82B | 1.70B | 1.89B | 1.99B |
Net Debt | ||||
1.19B | -193.00M | -2.08B | -416.00M | 288.00M |
Total Liabilities | ||||
8.46B | 7.81B | 10.60B | 11.44B | 7.44B |
Stockholders Equity | ||||
3.26B | 3.15B | 4.14B | 3.20B | 2.41B |
Cash Flow | Free Cash Flow | |||
1.18B | 1.39B | 4.16B | 2.26B | 1.53B |
Operating Cash Flow | ||||
1.48B | 1.70B | 4.40B | 2.46B | 1.72B |
Investing Cash Flow | ||||
-452.00M | -243.00M | -223.00M | -1.08B | 158.00M |
Financing Cash Flow | ||||
-1.91B | -3.12B | -2.64B | -800.00M | -1.04B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
75 Outperform | $16.49B | 20.95 | 35.12% | 1.22% | 13.98% | 14.29% | |
74 Outperform | $57.91B | 15.18 | 14.74% | 2.23% | 0.34% | -8.45% | |
72 Outperform | $92.99B | 16.22 | 33.99% | 5.95% | 0.16% | -13.41% | |
68 Neutral | $11.96B | 26.21 | 29.65% | 2.43% | 0.73% | 41.65% | |
66 Neutral | $27.86B | 20.73 | 36.53% | 2.41% | 6.30% | -15.39% | |
65 Neutral | $14.61B | 26.30 | 14.06% | 1.18% | -5.79% | -20.32% | |
62 Neutral | $8.06B | 13.61 | 3.91% | 3.11% | 3.80% | -14.06% |